1229 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
Rank Status Study
21 Completed Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders
Interventions: Drug: AFQ056;   Drug: Placebo
22 Completed Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Interventions: Drug: AFQ056;   Drug: Placebo
23 Completed Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsonian Disorders;   Basal Ganglia Diseases;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Movement Disorders;   Neurodegenerative Diseases
Interventions: Dietary Supplement: Whey protein;   Dietary Supplement: Soy protein
24 Enrolling by invitation Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication
Condition: Carbon Monoxide-induced Parkinsonism
Intervention: Drug: 18F-FP-(+)-DTBZ
25 Recruiting Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
26 Completed
Has Results
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Condition: Parkinsonian Syndromes
Intervention: Procedure: DaTSCAN SPECT imaging
27 Completed Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
28 Recruiting Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Conditions: Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
Intervention:
29 Enrolling by invitation Molecular Analysis of Human Neural Stem Cells
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Procedure: Harvesting of neural stem cells
30 Recruiting Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Conditions: Idiopathic Parkinson Disease;   Primary Parkinsonism
Intervention: Drug: Mesencephalic Neuronal Precursor Cells
31 Active, not recruiting A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Conditions: Parkinson's Disease;   Primary Parkinsonism;   Lewy Body Parkinson's Disease
Intervention: Drug: 18F-AV-133
32 Recruiting Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
Conditions: Neurological Diseases,;   Ischemic Stroke,;   Hemorrhagic Stroke,;   Cerebral Palsy,;   Atypical Parkinsonism
Interventions: Drug: Combination injection of EPO and G-CSF;   Drug: Injection of normal saline
33 Terminated Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
Conditions: Alzheimer's Disease;   Dementia;   Down's Syndrome
Intervention:
34 Completed Low Dose Apomorphine and Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: apomorphine
35 Completed Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
Conditions: Dementia;   Parkinson Disease
Intervention: Drug: Quetiapine
36 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
37 Active, not recruiting Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
Conditions: Parkinson Disease;   Gaucher Disease;   Idiopathic Rapid Eye Movement Sleep Disorder
Intervention:
38 Completed Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
Condition: Parkinson Disease
Interventions: Drug: Treatment A;   Drug: Treatment B;   Drug: Treatment C
39 Completed The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men
Condition: Parkinson's Disease
Intervention:
40 Completed The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Condition: Parkinson's Disease
Intervention: Drug: 18F-FDG

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years